CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
Testing for SARS CoV2 Antigendevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05612724
NCT05612724N/ACompleted

Rutgers Pilot for Pragmatic Return to Effective Dental Infection Control Through Triage and Testing (PREDICT)- Patient POC Test

Rutgers, The State University of New Jersey·interventional·Posted Nov 10, 2022·Updated Mar 27, 2024

In Brief

A clinical study evaluating Testing for SARS CoV2 Antigen for SARS CoV 2 Infection. Completed, enrolled 14 participants across 1 site.

Detailed Summary

A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral antigen using a point-of-care (POC) Rapid Antigen test. 14 subjects with upcoming appointment at the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated patients' perceptions of safety and feedback regarding their testing experience. All 14 patients expressed initial interest, however, 10 patients completed informed consent and completed study procedures. Institutional Clinical Laboratory Improvement Amendments (CLIA) certification of waiver was obtained prior to conducting the study. Communicable Diseases Reporting and Surveillance System (CDRSS) registration and training were completed to enable reporting results of the POC test.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 10, 2022
Enrollment StartDec 30, 2020
Primary CompletionJan 20, 2021
Study CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 20 daysPosted 3.6 years ago

Interventions

Testing for SARS CoV2 Antigendevice

Device: Testing for SARS CoV2 Antigen Antigen testing: Rapid Antigen testing (Point-of-care)